South Dakota · House

reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

On HB 1099 — reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Passed 58 Yea · 7 Nay · 5 Other ·

By party

Party YeaNayPresentNot Voting
Republican 51705
Democratic 5000
Unaffiliated 2000

How each member voted (70)